SCHEMBL21499668

SCHEMBL21499668

CN1C(=O)c2c(nc(Oc3cccc(OC(F)(F)F)c3)n2Cc2ccc(Cl)cc2)N(Cc2ccncc2)C1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPC5 Q9UL62 6/20 0.51
▸ TRPC4 Q9UBN4 2/20 0.51
▸ TRPC1 P48995 1/20 0.51
▸ P2RX3 P56373 5/20 0.42
▸ KCNH2 Q12809 2/20 0.38
▸ HCRTR1 O43613 4/20 0.37
▸ HCRTR2 O43614 4/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ ENPP2 Q13822 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ PPARG P37231 3/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ EGFR P00533 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ ADRB1 P08588 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ ADRB3 P13945 1/20 0.35
▸ DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19505209 0.94 TRPC5 (0.52) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL19505311 0.91 TRPC5 (0.53) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL18833641 0.90 TRPC5 (0.51) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL21316291 0.90 TRPC5 (0.54) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL21316299 0.89 TRPC5 (0.48) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL21499657 0.88 TRPC5 (0.52) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL19505055 0.86 TRPC5 (0.56) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL21499665 0.85 TRPC5 (0.51) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL19505445 0.84 TRPC5 (0.51) TRPC5TRPC4TRPC1P2RX3KCNH2
SCHEMBL19505070 0.84 TRPC5 (0.52) TRPC5TRPC4TRPC1P2RX3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TRPC5 1/4885TRPC4 3/4885TRPC1 4/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 TRPC5 1/4885TRPC4 3/4885TRPC1 4/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TRPC5 1/4885TRPC4 3/4885TRPC1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback